ArticleTherapeutic advances in medical oncology2024

Criteria for assessing evidence for biomarker-targeted therapies in rare cancers-an extrapolation framework.

Doah Cho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.